Milvexian TFA

SI-6927

Milvexian TFA, >98% (HPLC)

CAS No. : [1802426-00-1]

Synonyms : BMS-986177 TFA; JNJ-70033093 TFA

IUPAC Name : (5R,9S)-9-(4-(5-Chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl)-6-oxopyrimidin-1(6H)-yl)-21-(difluoromethyl)-5-methyl-21H-3-aza-1(4,2)-pyridina-2(5,4)-pyrazolacyclononaphan-4-one trifluoroacetate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Milvexian TFA is a potent factor XIa inhibitor with demonstrated efficacy in preventing venous thromboembolism (VTE). It significantly reduced VTE incidence in patients undergoing knee replacement surgery, shows good selectivity with notable inhibition of plasma kallikrein and trypsin, has an oral bioavailability of 32%, and exhibits a relatively low bleeding risk in clinical studies.

References : Pancras C. Wong et al.: Milvexian for the Prevention of Venous Thromboembolism; Xinkang W. et al.: T. H. Open., 7(2), e97–e104, 2023; Wong P. et al.: Res. Pract. Thromb. Haemost., 4 (Suppl 1), 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.